Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases.
Seminars in nuclear medicine.
Times cited: 91
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.
Times cited: 123